Why would a provider deny Wellbutrin?

Accessing medication for Binge Eating Disorder (BED) has become increasingly convenient through telehealth services. But with a patchwork of federal and state regulations, many patients wonder: Can I really get BED medication prescribed online? Is it legal in my state? Which providers can prescribe it? This comprehensive guide answers these questions with the latest regulatory information as of 2026.

Understanding Telehealth Prescribing for BED Treatments

Binge Eating Disorder affects millions of Americans, characterized by recurrent episodes of eating unusually large amounts of food while feeling a lack of control. While psychotherapy remains a cornerstone of treatment, medications like topiramate (Topamax) and bupropion (Wellbutrin) are commonly prescribed off-label to help manage BED symptoms.

The good news? These medications are not controlled substances, which means they’re subject to much fewer restrictions for telehealth prescribing compared to medications like stimulants or opioids.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Regulations: What You Need to Know

At the federal level, non-controlled medications like Topamax and Wellbutrin have never been restricted by the Ryan Haight Act, which primarily governs controlled substance prescribing via telehealth. This means federal law permits these medications to be prescribed through a telehealth visit without requiring an in-person evaluation first.

In January 2026, the DEA extended COVID-era telehealth flexibilities for controlled substances through December 31, 2026. While this extension doesn’t directly affect non-controlled BED medications, it signals continued federal support for telehealth accessibility overall.

State-by-State Telehealth Rules: Where Can You Get BED Medications Online?

States have their own telehealth regulations, but the vast majority allow prescribing of non-controlled medications like Topamax and Wellbutrin via telehealth without an in-person requirement. Here’s a snapshot of key state policies:

States with No In-Person Requirement for BED Medications:

• California: No in-person exam required if standard of care is met (telehealth exam, even asynchronous, qualifies)
• Delaware: Fully remote prescribing allowed under the Telehealth Act
• Florida: No in-person visit required for non-controlled prescriptions
• Michigan: Telehealth allowed if standard of care is met
• New York: No state in-person rule for legend drugs (non-controlled)
• Texas: No in-person exam required for non-controlled medications
• Wisconsin: Telehealth permitted by standard of care
• South Carolina: No explicit in-person requirement (telehealth evaluation is sufficient)

States Requiring Periodic In-Person Visits:

• Alabama: If you have more than 4 telehealth visits in 12 months for the same condition, an in-person visit is required within a year
• Georgia: Providers must attempt an in-person exam annually for ongoing telemedicine care
• New Hampshire: A subsequent in-person exam is required at least every 12 months for continued prescribing

Even in states requiring periodic in-person visits, you can typically start treatment completely via telehealth, and the follow-up requirement often allows flexibility (such as seeing a different collaborating provider or local physician).

Who Can Prescribe BED Medications Via Telehealth?

In all states, licensed physicians (MDs and DOs) can prescribe Topamax and Wellbutrin for BED via telehealth. However, nurse practitioner (NP) and physician assistant (PA) authority varies by state:

Full Practice Authority States:

In about 34 states plus DC, nurse practitioners have full practice authority, meaning they can independently evaluate and prescribe these medications without physician oversight. Recent additions to this list include Michigan and Wisconsin, which enacted full practice authority in 2025.

Collaborative Practice States:

In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must have a collaborative agreement with a physician to prescribe. This doesn’t typically affect your care as a patient—it’s a behind-the-scenes regulatory requirement—but you might see both the NP’s and collaborating physician’s names on your prescription.

The trend across the country has been toward expanding NP/PA practice authority, with several states transitioning to full practice models in recent years.

What to Expect During Telehealth Treatment for BED

When seeking BED treatment via telehealth, you can expect:

Initial Evaluation:

• Verification of your identity and location (required by many states)
• A thorough assessment of your eating behaviors and mental health
• Questions about meeting clinical criteria for BED (e.g., eating an extreme amount within 2 hours, feeling out of control, episodes occurring at least once weekly for 3 months)
• Discussion of your medical history, including any conditions that might affect medication selection

Prescribing Process:

• If appropriate, the provider will discuss medication options, including off-label use of topiramate or bupropion
• Explanation of risks, benefits, and potential side effects
• Electronic prescription sent directly to your preferred pharmacy
• Typical starting doses are low, with gradual titration as needed

Follow-up Care:

• Initial follow-up within 2-4 weeks to monitor how you’re tolerating the medication
• Regular check-ins (monthly or bimonthly) to assess progress
• Potential refills for up to 6-11 months (depending on state limits)
• Discussion of complementary treatments like therapy or nutritional counseling

At Klarity Health, we provide transparent care plans for BED treatment that include regular follow-ups with our providers to ensure you’re getting the right support throughout your treatment journey. Our licensed providers are available in most states, and we accept both insurance and offer affordable cash-pay options.

Safety Considerations and Exclusion Criteria

Not everyone is a good candidate for telehealth BED treatment. Providers will screen for conditions that might make these medications unsafe, including:

For Wellbutrin (Bupropion):

• History of seizures or seizure disorder
• Current or recent history of anorexia or bulimia (contraindicated due to seizure risk)
• Current alcohol abuse or abrupt discontinuation of alcohol or sedatives
• Use of MAO inhibitors within the past 14 days

For Topamax (Topiramate):

• Pregnancy or planning pregnancy (can cause birth defects)
• Metabolic acidosis risk factors
• Angle closure glaucoma
• Kidney stones or severe kidney disease

Patients with severe medical instability, very high suicide risk, or those needing controlled medications might be referred for in-person care. Legitimate telehealth providers prioritize patient safety and will not prescribe if telehealth isn’t appropriate for your situation.

Prescription Monitoring and Documentation

Although most states don’t mandate checking the Prescription Monitoring Program (PMP) database for non-controlled medications like Topamax and Wellbutrin, many providers will still review your medication history as a precaution. This helps ensure you’re not inadvertently taking duplicate medications or combinations that might interact.

Proper documentation is critical in telehealth. Your provider will document that you meet DSM-5 criteria for BED, that they obtained informed consent for telehealth, and that an appropriate evaluation was conducted.

The Off-Label Medication Conversation

Both topiramate and bupropion are prescribed ‘off-label’ for BED, meaning they’re FDA-approved for other conditions (seizures/migraines for topiramate; depression/smoking cessation for bupropion) but have clinical evidence supporting their use in BED.

Off-label prescribing is legal, common, and often supported by clinical guidelines. Your telehealth provider should explain this clearly and document your informed consent. Don’t hesitate to ask questions about why a particular medication is being recommended and what alternatives exist.

Recent Developments and Trends (2025-2026)

The regulatory landscape for telehealth continues to evolve:

• The DEA extended pandemic-era flexibilities for controlled substance prescribing through 2026
• Several states have updated their telehealth laws to provide more permanent frameworks
• New York implemented rules requiring in-person visits for controlled substance prescriptions (but not affecting non-controlled medications like those used for BED)
• More states have granted full practice authority to nurse practitioners

These developments generally maintain or expand telehealth access for BED medications while implementing safeguards around controlled substances.

Choosing a Quality Telehealth Provider

When selecting a telehealth provider for BED treatment, look for:

1. Legitimate evaluation process – The initial assessment should be thorough (often 30+ minutes)
2. Licensed providers in your state with relevant experience
3. Transparent prescribing policies – They should clearly explain their approach to medication
4. Comprehensive treatment planning –

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12